Home | Publications | Medical Devices place holder
place holder place holder

Medical Devices

United Kingdom Diabetes Care Devices Investment Opportunities

Analysis and Forecasts to 2012

Publication Date   August 2008
Publisher   Global Markets Direct
Product Type   Report
Pages   83
ISBN Number   not applicable
Product Code   GMD1158
Ask a question about this product?

Price £1,045.00

approximately: $1,603 | €1,229

Summary


United Kingdom Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2012

Summary

This report is an essential source for in-depth information and data relating to the UK diabetes care devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the diabetes care devices in United Kingdom.

Scope

  • The report provides diabetes care devices information broken down into detailed categories and segments in United Kingdom.
  • Total revenues, products sold, end users, and average pricing.
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.

Reasons to buy

  • Gain a strong understanding of the diabetes care devices market in United Kingdom.
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Content


  • 1 List of Tables
    • 1.2 List of Figures
  • 2 Introduction
    • 2.1 What Is This Report About?
  • 3 Definitions of the Markets Covered in the Report
    • 3.1 Diabetes Care Devices
    • 3.2 Glucose Monitoring
      • 3.2.1 Blood Glucose Meter
      • 3.2.2 Blood Glucose Strips
    • 3.3 Insulin Delivery
      • 3.3.1 Insulin Jet Injector
      • 3.3.2 Insulin Pen
      • 3.3.3 Insulin Pump
      • 3.3.4 Insulin Syringes
  • 4 Healthcare Sector Review
    • 4.1 Healthcare Expenditure
    • 4.2 Healthcare Infrastructure
    • 4.3 Healthcare Policy
  • 5 Regulation System
    • 5.1 Medical Equipment Approval Process
      • 5.1.1 Classification of Medical Devices
      • 5.1.2 Conformity Assessment Process
        • 5.1.2.1 Class I devices
        • 5.1.2.2 Class IIa devices
        • 5.1.2.3 Class IIb devices
        • 5.1.2.4 Class III devices
    • 5.2 Medical Device approval fee
    • 5.3 Post Market Surveillance (PMS)
  • 6 Pricing and Reimbursement
    • 6.1 Market Pricing
    • 6.2 Government Policies for Reimbursement
  • 7 Distribution Structure
  • 8 United Kingdom Medical Equipment Cross Market Comparison
  • 9 Diabetes Care Devices In United Kingdom
    • 9.1 Diabetes Care Devices Cross Country Comparison (2000-2012)
    • 9.2 Diabetes Care Devices, United Kingdom, Overall Revenues ($ mn), 2000-2012
    • 9.3 Diabetes Care Devices, United Kingdom, Category Volume (Units), 2000-2012
    • 9.4 Diabetes Care Devices, United Kingdom Company Share (2006-2007)
  • 10 Glucose Monitoring In United Kingdom
    • 10.1 Glucose Monitoring Overall Revenue (2000-2012)
    • 10.2 Glucose Monitoring Overall Volume (2000-2012)
    • 10.3 Glucose Monitoring Average Price (2000-2012)
    • 10.4 Glucose Monitoring Distribution Share (2006-2007)
    • 10.5 Glucose Monitoring, United Kingdom Company Share (2006-2007)
  • 11 Insulin Delivery In United Kingdom
    • 11.1 Insulin Delivery Overall Revenue (2000-2012)
    • 11.2 Insulin Delivery Overall Volume (2000-2012)
    • 11.3 Insulin Delivery Average Price (2000-2012)
    • 11.4 Insulin Delivery Distribution Share (2006-2007)
    • 11.5 Insulin Delivery, United Kingdom Company Share (2006-2007)
  • 12 F. Hoffmann-La Roche Ltd. Company Profile
    • 12.1 Company Overview
    • 12.2 Value Chain Analysis
      • 12.2.1 Manufacturing
        • 12.2.1.1 In House Manufacturing
        • 12.2.1.2 Outsourcing
      • 12.2.2 Product Development
        • 12.2.2.1 Regulatory Approvals
        • 12.2.2.2 Clinical Trials
        • 12.2.2.3 Research and Development
      • 12.2.3 Sales and Marketing
        • 12.2.3.1 Partnerships and Alliances
        • 12.2.3.2 Licensing Agreements
  • 13 Novo Nordisk A/S Company Profile
    • 13.1 Company Overview
    • 13.2 Novo Nordisk A/S Pipeline Products
      • 13.2.1 Novo Nordisk A/S Pipeline Products by Equipment Type
      • 13.2.2 Novo Nordisk A/S Pipeline Products by Development Stage
      • 13.2.3 Novo Nordisk A/S Pipeline Products by Therapy Area
  • 14 LifeScan, Inc. Company Profile
    • 14.1 Company Overview
    • 14.2 LifeScan, Inc. Pipeline Products
      • 14.2.1 LifeScan, Inc. Pipeline Products by Equipment Type
      • 14.2.2 LifeScan, Inc. Pipeline Products by Development Stage
      • 14.2.3 LifeScan, Inc. Pipeline Products by Therapy Area
      • 14.2.4 LifeScan, Inc. Pipeline Products by News Summary
  • 15 Bayer HealthCare AG Company Profile
    • 15.1 Company Overview
    • 15.2 Value Chain Analysis
      • 15.2.1 Manufacturing
        • 15.2.1.1 In House Manufacturing
        • 15.2.1.2 Outsourcing
      • 15.2.2 Product Development
        • 15.2.2.1 Regulatory Approvals
        • 15.2.2.2 Clinical Trials
        • 15.2.2.3 Research and Development
      • 15.2.3 Sales and Marketing
        • 15.2.3.1 Partnerships and Alliances
        • 15.2.3.2 Licensing Agreements
    • 15.3 Bayer HealthCare AG Pipeline Products
      • 15.3.1 Bayer HealthCare AG Pipeline Products by Equipment Type
      • 15.3.2 Bayer HealthCare AG Pipeline Products by Development Stage
      • 15.3.3 Bayer HealthCare AG Pipeline Products by Therapy Area
      • 15.3.4 Bayer HealthCare AG Pipeline Products by News Summary
  • 16 Becton, Dickinson and Company Profile
    • 16.1 Company Overview
    • 16.2 Value Chain Analysis
      • 16.2.1 Manufacturing
        • 16.2.1.1 In House Manufacturing
      • 16.2.2 Product Development
        • 16.2.2.1 Regulatory Approvals
        • 16.2.2.2 Research and Development
      • 16.2.3 Sales and Marketing
        • 16.2.3.1 Partnerships and Alliances
  • 17 Abbott Laboratories Company Profile
    • 17.1 Company Overview
    • 17.2 Value Chain Analysis
      • 17.2.1 Manufacturing
        • 17.2.1.1 In House Manufacturing
      • 17.2.2 Product Development
        • 17.2.2.1 Regulatory Approvals
        • 17.2.2.2 Research and Development
        • 17.2.2.3 Clinical Trials
      • 17.2.3 Sales and Marketing
        • 17.2.3.1 Partnerships and Alliances
    • 17.3 Abbott Laboratories Pipeline Products
      • 17.3.1 Abbott Laboratories Pipeline Products by Equipment Type
      • 17.3.2 Abbott Laboratories Pipeline Products By Development Stage
      • 17.3.3 Abbott Laboratories Pipeline Products by Therapy Area
      • 17.3.4 Abbott Laboratories Pipeline Products by Clinical Trials
      • 17.3.5 Abbott Laboratories Pipeline Products by News Summary
  • 18 Bailey Instruments Ltd. Company Profile
    • 18.1 Company Overview
  • 19 Financial Deals Landscape
    • 19.1 Partnership
      • 19.1.1 Analogic Corporation Signs An Agreement With Sphere Medical
    • 19.2 Asset Transactions
      • 19.2.1 Bio-Rad Laboratories Acquires Medical Diagnostics Business From Provalis
  • 20 Appendix
    • 20.1 Global Markets Direct Research Methodology
    • 20.2 Coverage
    • 20.3 Secondary Research
    • 20.4 Primary Research
    • 20.5 Models
    • 20.6 Forecasts
    • 20.7 Expert Panels
    • 20.8 Currency Conversion
    • 20.9 Contact Us
    • 20.10 Disclaimer
  • LIST OF TABLES
  • 1 List of Tables
    • Table 1: Number of Doctor by Specialty in UK, 2003 - 2007
    • Table 2: Medical Device Approval Fee in UK, 2006
    • Table 3: United Kingdom, Medical Equipment Market Comparison
    • Table 4: Diabetes Care Devices Cross Country Comparison (2000-2012)
    • Table 5: Diabetes Care Devices, United Kingdom, Overall Revenues ($ mn), 2000-2012
    • Table 6: Diabetes Care Devices Market, United Kingdom, Portfolio Analysis
    • Table 7: Diabetes Care Devices, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 8: Diabetes Care Devices, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 9: Diabetes Care Devices, United Kingdom, Category Volume (Units), 2000-2012
    • Table 10: Diabetes Care Devices, United Kingdom, Category Volume (Units), Historic, 2000-2007
    • Table 11: Diabetes Care Devices, United Kingdom, Category Volume (Units), Forecast, 2007-2012
    • Table 12: Diabetes Care Devices, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
    • Table 13: Glucose Monitoring, United Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Table 14: Glucose Monitoring, United Kingdom, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Table 15: Glucose Monitoring, United Kingdom, Overall Volume (Units), Historic, 2000-2007
    • Table 16: Glucose Monitoring, United Kingdom, Overall Volume (Units), Forecast, 2007-2012
    • Table 17: Glucose Monitoring, United Kingdom, Average Price ($), Historic, 2000-2007
    • Table 18: Glucose Monitoring, United Kingdom, Average Price ($), Forecast, 2007-2012
    • Table 19: Glucose Monitoring, United Kingdom, Distribution Share by Revenue ($ mn), 2006-2007
    • Table 20: Glucose Monitoring, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
    • Table 21: Insulin Delivery, United Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Table 22: Insulin Delivery, United Kingdom, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Table 23: Insulin Delivery, United Kingdom, Overall Volume (Units), Historic, 2000-2007
    • Table 24: Insulin Delivery, United Kingdom, Overall Volume (Units), Forecast, 2007-2012
    • Table 25: Insulin Delivery, United Kingdom, Average Price ($), Historic, 2000-2007
    • Table 26: Insulin Delivery, United Kingdom, Average Price ($), Forecast, 2007-2012
    • Table 27: Insulin Delivery, United Kingdom, Distribution Share by Revenue ($ mn), 2006-2007
    • Table 28: Insulin Delivery, United Kingdom Company Share by Revenue ($ mn), 2006-2007
    • Table 29: Nordisk A/S Pipeline Products by Equipment Type
    • Table 30: Novo Novo Nordisk A/S Pipeline Products By Development Stage
    • Table 31: Novo Nordisk A/S Pipeline Products By Therapy Area
    • Table 32: LifeScan, Inc. Pipeline Products by Equipment Type
    • Table 33: LifeScan, Inc. Pipeline Products By Development Stage
    • Table 34: LifeScan, Inc. Pipeline Products By Therapy Area
    • Table 35: LifeScan, Inc. Pipeline Products By News Summaries
    • Table 36: Bayer HealthCare AG Pipeline Products by Equipment Type
    • Table 37: Bayer HealthCare AG Pipeline Products By Development Stage
    • Table 38: Bayer HealthCare AG Pipeline Products By Therapy Area
    • Table 39: Bayer HealthCare AG Pipeline Products By News Summaries
    • Table 40: Abbott Laboratories Pipeline Products by Equipment Type
    • Table 41: Abbott Laboratories Pipeline Products By Development Stage
    • Table 42: Abbott Laboratories Pipeline Products By Therapy Area
    • Table 43: Abbott Laboratories Pipeline Products By Clinical Trials
    • Table 44: Abbott Laboratories Pipeline Products By News Summaries
    • Table 45: Currency Conversion from USD to Local Currency at 2007 Constant Rate
  • LIST OF FIGURES
    • 1.2 List of Figures
    • Figure 1: Total Healthcare Expenditure in UK, 2000 - 2006
    • Figure 2: Flowchart for Classification of Non-invasive Devices in UK, 2007
    • Figure 3: Flowchart for Classification of Invasive Devices in UK, 2007
    • Figure 4: Flowchart for Classification of Invasive Devices in UK, 2007
    • Figure 5: Flowchart for Classification of Invasive Devices in UK, 2007
    • Figure 6: Flowchart for Classification of Invasive Devices in UK, 2007
    • Figure 7: Flowchart for Classification of Active Devices in UK, 2007
    • Figure 8: Flowchart for Classification of Active Devices in UK, 2007
    • Figure 9: Flowchart for Classification of Devices except Non-invasive, Invasive and Active Devices in UK, 2007
    • Figure 10: Conformity Assessment of Class-I Medical Devices in UK, 2007
    • Figure 11: Conformity Assessment of Class-IIa Medical Devices in UK, 2007
    • Figure 12: Conformity Assessment of Class-IIb Medical Devices in UK, 2007
    • Figure 13: Conformity Assessment of Class-III Medical Devices in UK, 2007
    • Figure 14: United Kingdom, Medical Equipment Market Comparison, 2007
    • Figure 15: Diabetes Care Devices Cross Country Comparison (2000-2012)
    • Figure 16: Diabetes Care Devices, United Kingdom, Overall Revenues ($ mn), 2000-2012
    • Figure 17: Diabetes Care Devices Market, United Kingdom, Portfolio Analysis
    • Figure 18: Diabetes Care Devices, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 19: Diabetes Care Devices, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 20: Diabetes Care Devices, United Kingdom, Category Volume (Units), 2000-2012
    • Figure 21: Diabetes Care Devices, United Kingdom, Category Volume (Units), Historic, 2000-2007
    • Figure 22: Diabetes Care Devices, United Kingdom, Category Volume (Units), Forecast, 2007-2012
    • Figure 23: Diabetes Care Devices, United Kingdom, Company Share (%), 2007
    • Figure 24: Glucose Monitoring, United Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Figure 25: Glucose Monitoring, United Kingdom, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Figure 26: Glucose Monitoring, United Kingdom, Overall Volume (Units), Historic, 2000-2007
    • Figure 27: Glucose Monitoring, United Kingdom, Overall Volume (Units), Forecast, 2007-2012
    • Figure 28: Glucose Monitoring, United Kingdom, Company Share (%), 2007
    • Figure 29: Insulin Delivery, United Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Figure 30: Insulin Delivery, United Kingdom, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Figure 31: Insulin Delivery, United Kingdom Company Share (%), 2007
    • Figure 32: F. Hoffmann-La Roche Ltd Value Chain Analysis
    • Figure 33: Bayer HealthCare AG Value Chain Analysis
    • Figure 34: Becton, Dickinson and Company Value Chain Analysis
    • Figure 35: Abbott Laboratories Value Chain Analysis
    • Figure 36: Global Markets Direct Methodology